STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

ENANTA PHARMACEUTICALS INC

Filed

December 10, 2024

Period of Report

December 6, 2024

Accession Number

0001062993-24-020386